ISTA Pharmaceuticals (ISTA) says during its guidance and pipeline update that it expects 2012...


ISTA Pharmaceuticals (ISTA) says during its guidance and pipeline update that it expects 2012 earnings and revenue to come in below estimates. It now expects its EPS to be between $0.28 - $0.39 on revenue of around $180M -$195M.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs